Form 4 Moderna, Inc. For: Nov 08 Filed by: Hoge Stephen
Moderna, Inc. (MRNA)
Last moderna, inc. earnings: 2/26 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
marinabio.com/investor-relations
Company Research
Source: SEC EDGAR
Impact Snapshot
Event Time:
MRNA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MRNA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MRNA alerts
High impacting Moderna, Inc. news events
Weekly update
A roundup of the hottest topics
MRNA
News
- Moderna, Inc. (MRNA) Jefferies London Healthcare Conference (Transcript) [Seeking Alpha]Seeking Alpha
- Moderna, Inc. (NASDAQ: MRNA) is now covered by analysts at Berenberg Bank. They set a "hold" rating and a $42.00 price target on the stock.MarketBeat
- Moderna, Inc. (NASDAQ: MRNA) was upgraded by analysts at Hsbc Global Res from a "hold" rating to a "strong-buy" rating.MarketBeat
- Moderna, Inc. (NASDAQ: MRNA) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $69.00 price target on the stock, down previously from $115.00.MarketBeat
- Moderna, Inc. (NASDAQ: MRNA) was upgraded by analysts at HSBC Holdings plc from a "hold" rating to a "buy" rating. They now have a $58.00 price target on the stock.MarketBeat
MRNA
Earnings
- 11/7/24 - Beat
MRNA
Sec Filings
- 11/12/24 - Form 144
- 11/7/24 - Form 10-Q
- 11/7/24 - Form 8-K
- MRNA's page on the SEC website